Xencor, Inc. (XNCR) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Xencor, Inc.
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia…
Source: Yahoo Finance
Sector & Industry
Xencor, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Xencor, Inc. at a Glance
| Company | Xencor, Inc. |
| Ticker | XNCR |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $26.61 |
| Market cap | $1.98B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$2.16 |
| 52-week high | $30.61 |
| 52-week low | $8.19 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.88 |
| Return on equity (ROE) | -29.07% |
| Debt-to-equity | 33.80% |
| Average volume | 1.15M |
| Shares outstanding | 74.35M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 260 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Xencor, Inc.'s current P/E ratio?
- Xencor, Inc. (XNCR) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Xencor, Inc.'s market capitalisation?
- Xencor, Inc.'s market cap is $1.98B based on our latest snapshot. See how it ranks by market cap →
- What is XNCR's 52-week range?
- Over the past 52 weeks, XNCR has traded between $8.19 and $30.61. What does the 52-week range mean? →
- How volatile is Xencor, Inc. compared to the market?
- Xencor, Inc. has a beta of 0.88, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Xencor, Inc. pay a dividend?
- Xencor, Inc. does not currently pay a dividend according to our latest data.
- What exchange is XNCR listed on?
- XNCR is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Xencor, Inc. in?
- Xencor, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →